EPZICOM
- Product NDC
- 49702-206
- 11-digit product format
- 497020206
- Labeler code
- 49702
- Product ID
- 49702-206_532f9480-523b-49ed-8df1-1aa4317706c3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- abacavir sulfate and lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- ViiV Healthcare Company
- Application
- NDA021652
- Marketing category
- NDA
- Marketing start
- 2010-10-12
- Marketing end
- 0000-00-00
- Substance
- ABACAVIR SULFATE; LAMIVUDINE
- Active strength
- 600 mg/1; mg/1
- Pharmacologic classes
- Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| LAMIVUDINE | ACTIVE INGREDIENT | 2T8Q726O95 | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| ABACAVIR | ACTIVE MOIETY | WR2TIP26VS | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| LAMIVUDINE | ACTIVE MOIETY | 2T8Q726O95 | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 49702-206 | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 29 | Legacy NDC | 20240615_f1139e7f-2db9-4961-9da3-9b7f2088736f.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 49702-206-13 | 49702020613 | 30 TABLET, FILM COATED in 1 BOTTLE (49702-206-13) | 2010-10-12 | 0000-00-00 | No | No | Current |